May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Quality of Life in Patients With Choroidal Neovascular Membrane Treated With Indocyanine Green–Mediated Photothrombosis
Author Affiliations & Notes
  • A.T. Pinto
    Ophthalmology, UNIFESP, São Paulo, Brazil
  • M.Z. Johanson
    Ophthalmology, UNIFESP, São Paulo, Brazil
  • H.S. Jiun
    Ophthalmology, UNIFESP, São Paulo, Brazil
  • R. Sobrinha
    Ophthalmology, UNIFESP, São Paulo, Brazil
  • C. Souza
    Ophthalmology, UNIFESP, São Paulo, Brazil
  • P.P. Bonomo
    Ophthalmology, UNIFESP, São Paulo, Brazil
  • Footnotes
    Commercial Relationships  A.T. Pinto, None; M.Z. Johanson, None; H.S. Jiun, None; R. Sobrinha, None; C. Souza, None; P.P. Bonomo, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 296. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.T. Pinto, M.Z. Johanson, H.S. Jiun, R. Sobrinha, C. Souza, P.P. Bonomo; Quality of Life in Patients With Choroidal Neovascular Membrane Treated With Indocyanine Green–Mediated Photothrombosis . Invest. Ophthalmol. Vis. Sci. 2005;46(13):296.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To measure the impact in the quality of life and the ability to care for self or provide care to others in older people with age related macular degeneration (AMD) treated with Indocyanine Green–Mediated Photothrombosis (I–MP). Methods: Prospective non–controlled study of aged people with visual impairment due to AMD treated with I–MP in a specialized retinal service clinic. The inclusion criteria were patients with subfoveal choroidal neovascular membranes in the second eye with visual acuity (ETDRS chart) from 20/40 to 20/800 and neurosensory retinal detachment by OCT treated with I–MP. Eighteen patients (Fifty four questionnaires) submitted to AMD treatment who underwent visual function assessment (fully corrected distance by ETDRS chart) were analyzed, followed by the filling of some questionnaires concerning general health status (SF36) and the ability to care for self or provide care to others. The questionnaires were applied in the day of the treatment, 3 months and 6 months after the I–MP treatment. The preoperative scores were compared to 6 months postoperative outcomes. Results: A total of 15 patients completed 6 months of follow up. There were 06 women and 09 men with ages ranging from 61 to 88 years with a mean of 73.4 (SD 6.81). The mean baseline overall preoperative score was 67 points and 77 after 6 months I–MP treatment. The largest difference between preoperative and postoperative scores was observe for the physical limitations (31.66 points) and the smallest difference was observed for the functional capacity (3 points). All the subscale with exception of Except General Health had enlargement a median of points and Physical Limitation, Pain, Physical Health and Total Quality of life had a p<0.05. Conclusions: Participants reported poor vision–related functioning, but all report a subjective improvement and Total Quality of Life increase in value. Further studies must be done.

Keywords: quality of life • macula/fovea • drusen 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×